Moleculin Biotech Inc.

0.99
-0.16 (-13.91%)
At close: Mar 04, 2025, 9:46 AM

Moleculin Biotech Cash Flow Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Net Income -29.77M -29.02M -15.89M -17.36M -13.21M -11.88M -9.8M -3.93M -748.36K
Depreciation & Amortization 127K 130K 164K 200K 199K 68K 18K 6.16K n/a
Stock-Based Compensation 1.98M 2.27M 2.37M 1.68M 1.54M 1.14M 707K 411.47K n/a
Other Working Capital 1.22M -507K 803K 983K -3.05M 1.17M 131K 40.87M 322.79K
Other Non-Cash Items 1.94M -1.24M 96K 85K 476K -3.15M 2.6M 423.8K 2.06K
Deferred Income Tax n/a n/a -6.73M -2.34M -4.06M n/a -1.39M n/a n/a
Change in Working Capital 1.62M 224K 1.04M -41K -2.14M 1.61M 542K -256.18K 322.79K
Operating Cash Flow -24.1M -27.64M -18.95M -17.77M -17.2M -12.2M -7.32M -3.76M -423.51K
Capital Expenditures -124K -67K -19K -376K -52K -417K -28K -21.47K n/a
Acquisitions n/a n/a n/a 2K 1K n/a n/a -99.64K n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies n/a n/a n/a 2.00 1.00 n/a n/a n/a n/a
Investing Cash Flow -124K -67K -19K -374K -51K -417K -28K -121.11K n/a
Debt Repayment n/a n/a n/a n/a n/a n/a n/a -304.94K 450K
Common Stock Repurchased n/a -23 n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 485K -23K 40K -12K 1.56M 20K 3.99M -61 n/a
Financial Cash Flow 4.65M -23K 74.72M 22.55M 20.85K 12.04M 10.06M 8.87M 451.6K
Net Cash Flow -19.59M -27.76M 55.73M 4.44M 3.6M -580K 2.71M 4.98M 28.09K
Free Cash Flow -24.23M -27.71M -18.97M -18.15M -17.25M -12.62M -7.35M -3.79M -423.51K